Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 11/09/2026			5-day change	1st Jan Change
12.64 ^MXN	-0.86%		-2.84%	-29.35%

01/09	Genomma Lab Internacional, S.A.B. de C.V. Enters Into MXN 1.0 Billion Long-Term Credit Facility With Banamex	CI
24/07	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	12,324	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-29.47%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	16,515	15,990	15,557
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-25.75%	-3.18%	-2.71%
P/E	14.9x	12x	13.1x	11.7x	11.1x	6.68x	6.4x	5.73x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.87x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.4x	1.47x	0.5x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.69x	0.66x	0.62x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.92x	0.85x	0.78x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.04x	3.74x	3.41x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.42x	4.11x	3.75x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	11.5x	8.03x	7.24x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	8.71%	12.5%	13.8%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8003	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	6.33%	8.48%	11.4%
EPS ²	1.44	1.41	1.08	2.14	1.61	1.893	1.975	2.206
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	42.3%	54.2%	65.3%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	17,991	18,740	19,945
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,090	4,279	4,559
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,733	3,886	4,146
Net income ¹	1,451	1,397	1,031	2,137	1,607	1,906	2,058	2,285
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,190	3,666	3,233
Reference price ²	21.48	16.94	14.16	25.13	17.89	12.64	12.64	12.64
Nbr of stocks (in thousands)	10,06,240	9,94,639	9,29,461	9,24,946	9,76,728	9,75,033	-	-
Announcement Date	23/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	6.68x	0.92x	4.04x	6.33%	73Cr
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	99TCr
JOHNSON & JOHNSON	29.54x	-	-	2.02%	64TCr
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	45TCr
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	34TCr
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	26TCr
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	25TCr
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	20TCr
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	19TCr
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	18TCr
Average	15.21x	5.67x	13.83x	2.89%	35.06TCr
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%